US 12195447
Azolopyrimidine for the treatment of cancer-related disorders
granted A61KA61K31/506A61K31/5377
Quick answer
US patent 12195447 (Azolopyrimidine for the treatment of cancer-related disorders) held by Arcus Biosciences, Inc. expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arcus Biosciences, Inc.
- Grant date
- Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/506, A61K31/5377, A61K45/06, A61P